SLP-76-Cbl-Grb2-Shc interactions in Fcγ/RI signaling

Blood

Volumn 92, Issue 5, 1998, Pages 1697-1706

  Chu, Julie ^b   Liu, Yenbou ^b   Koretzky, Gary A ^b   Durden, Donald L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0032170564     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1697     Document Type: Article

References (55)

1. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76:263, 1994
2. Cambier JC: Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 155:3281, 1995
3. Samelson LE, Klausner RD: Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor. J Biol Chem 267:24913, 1992
4. Durden DL, Kim HM, Calore B, Liu Y: The FcγRI receptor signals through the activation of hck and MAP kinase. J Immunol 154:4039, 1995
5. Crowley MTCP, Fitzer-Attas CJ, Turner M, Meng FY, Lowell C, Tybulewicz VLJ, DeFranco AL: A critical role for Syk in signal transduction and phagocytosis mediated by Fc-γ receptors on macrophages. J Exp Med 186:1027, 1997
6. Durden DL, Liu YB: Protein-tyrosine kinase p72syk in Fc-γRI receptor signaling. Blood 84:2102, 1994
7. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, Bolen JB, Ledbetter JA: Cross-linking of Fcγ receptor I (FcγRI) and receptor II (FcγRII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J Biol Chem 268:24442, 1993
8. Wang Y, Yeung YG, Langdon WY, Stanley ER: c-Cb is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J Biol Chem 271:17, 1996
9. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG: Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689, 1992
10. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45, 1993
11. Basu T, Warne PH, Downward J: Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor. Oncogene 9:3483, 1994
12. Goga A, McLaughilin J, Afar DEH, Saffran DC, Witte ON: Alternative signals to RAS for haematopoetic transformation by the BCR-ABL oncogene. Cell 82:981, 1995
13. Gotoh N, Tojo A, Muroya K, Hashimoto Y, Hattori S, Nakamura S, Takenawa T, Yazaki Y, Shibuya M: Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Sch protein and Shc-Grb2/Ash association and retains mitogenic activity. Proc Natl Acad Sci USA 91:167, 1994
14. Gotoh N, Muroya K, Hattori S, Nakamura S, Chida K, Shibuya M: The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner. Oncogene 11:2525, 1995
15. Pawson T: Protein modules and signaling networks. Nature 373:573, 1995
16. Pronk GJ, Vries-Smits AMM, Buday L, Downward J, Maasen JA, Medema RH, Bos JL: Involvement of Shc in insulin and epidermal growth factor-induced activation of p21ras. Mol Cell Biol 14:1575, 1994
17. Skolnik EY, Lee CH, Batzer AG, Vincentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, Schlessinger J: The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of Ras signaling. EMBO J 12:1929, 1993
18. Pelieci G, Lanfraneone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Pawson T, Pelicci PG: A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93, 1992
19. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B: A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem 269:32031, 1994
20. Kavanaugh WM, Williams LT: An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862, 1994
21. Galisteo ML, Dikie I, Batzer AG, Langdon WY, Schlessinger J: Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EOF) receptor upon EGF stimulation. J Biol Chem 270:20242, 1995
22. Liu Y-C, Elly C, Langdon WY, Altman A: Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J Biol Chem 272:168, 1997
23. Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HCd: v-cbl, an oncogene from a dual-recombinant murine retrovirus that Linduces early B-lineage lymphomas. Proc Natl Acad Sci USA 86:1168, 1989
24. Blake TJ, Shapiro M, Morse HCd, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653, 1991
25. Lupher MLJ, Reedquist KA, Miyake S, Langdon WY, Band H: A novel phosphotyrosine-binding domain in the n-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J Biol Chem 271:24063, 1996
26. Blake TJ, Heath KG, Langdon WY: The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. Embo J 12:2017, 1993
27. Langdon WY: The cbl oncogene: A novel substrate of protein tyrosine kinases. Aust N Z J Med 25:859, 1995
28. Meisner H, Czech MP: Coupling of the proto-oncogene product c-Cb to the epidermal growth factor receptor. J Biol Chem 270:25332, 1995
29. Tanaka S, Neff L, Baron R, Levy JB: Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 270:14347, 1995
30. Cory GO, Lovering RC, Hinshelwood S, MacCarthy Morrogh L, Levinsky RJ, Kinnon C: The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 182:611, 1995
31. Donovan JA, Wange RL, Lanedon WY, Samelson LE: The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 269:22921, 1994
32. Park RK, Liu Y, Durden DL: A role for Shc, Grb2, and Raf-1 in FcγRI signal relay. J Biol Chem 271:13342, 1996
33. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H: Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem 271:8435, 1996
34. Erdreich-Epstein A, Liu M, Liu Y, Durden DL: Protein tyrosine phosphatase inhibitors in FcγRI-induced myeloid oxidant signaling. Exp Cell Res 237:288, 1997
35. Park RK, Kyono WT, Liu Y, Durden DL: CbKGrb2 interaction in myeloid immunoreceptor tyrosine activation motif (ITAM) signaling. J Immunol 160:5010, 1998
36. Jackman JK, Motto DC, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA, Findell PR: Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem 270:7029, 1995
37. Motto DG, Ross SE, Wu J, Hendricks Taylor LR, Koretzky GA: Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J Exp Med 183:1937, 1996
38. Wu J, Motto DG, Koretzky GA, Weiss A: Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593, 1996
39. Raab M, da Silva AJ, Findell PR, Rudd CE: Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity 6:155, 1997
40. Mizuno K, Katagin T, Hasegawa K, Ogimoto M, Yakura H: LLLHematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells. J Exp Med 184:457, 1996
41. Robinson A, Gibbins J, Rodriguez Linares B, Finan PM, Wilson L, Kellie S, Findell P, Watson SP: Characterization of Grb2-binding proteins in human platelets activated by FcγRIIA cross-linking. Blood 88:522, 1996
42. Hendricks-Taylor RL, Motto DG, Zhang J, Siraganian RP, Koretzky GA: SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells. J Biol Chem 272:1363, 1997
43. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ: Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Mol Cell Biol 15:593, 1995
44. Liu YC, Elly C, Yoshida H, Bonnefoy Berard N, Altman A: Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J Biol Chem 271:14591, 1996
45. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B, Schlessinger J: Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363:85, 1993
46. Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J: A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem 269:9019, 1994
47. Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG: Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827, 1994
48. Wardenburg JB, Fu C, Jackman JK, Flotow H, Wilkinson SE, Williams DH, Johnson R, Kong G, Chan AC, Findell PR: Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J Biol Chem 271:19641, 1996
49. Bonita DP, Miyake S, Lupher ML, Jr., Langdon WY, Band H: Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cb: Implications for Cbl's function and oncogenicity. Mol Cell Biol 17:4597, 1997
50. Indik ZKPJ, Hunter S, Schreiber AD: The molecular dissection of Fcγ receptor mediated phagocytosis. Blood 86:4389, 1995
51. Yoon CH, Lee J, Jongeward GD, Sternberg PW: Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269:1102, 1995
52. Rellahan BL, Graham LJ, Stoica B, DeBell KE, Bonvini E: Cb-mediated regulation of T cell receptor-induced AP1 activation. J Biol Chem 272:30806, 1997
53. Musci MA, Motto DG, Ross SE, Fang N, Koretzky GA: Three domains of SLP-76 are required for its optimal function in a T cell line. J Immunol 159:1639, 1997
54. Fang N, Motto DG, Ross SE, Koretzky GA: Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J Immunol 157:3769, 1996
55. Marengere LEM, Mirtsos C, Kozieradzki I, Veillette A, Mak TW, Penninger JM: Proto-oncoprotein Vav interacts with c-Cb in activated thymocytes and peripheral T cells. J Immunol 159:70, 1997